RILPIVIRINE HYDROCHLORIDE

RILPIVIRINE HYDROCHLORIDE was reported 6728 times

RILPIVIRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARTERIOVENOUS GRAFT SITE PSEUDOANEURYSM 3 0.6000
1 MYCOPLASMA GENITALIUM INFECTION 9 0.4737
2 PROCTITIS GONOCOCCAL 2 0.2000
3 PROCTITIS CHLAMYDIAL 2 0.1818
4 CONGENITAL PYELOCALIECTASIS 20 0.1667
5 HYPO HDL CHOLESTEROLAEMIA 2 0.1538
6 BLOOD HIV RNA BELOW ASSAY LIMIT 2 0.1333
7 OROPHARYNGEAL GONOCOCCAL INFECTION 3 0.1111
8 HEPATITIS SYPHILITIC 2 0.1111
9 BRAIN STEM HAEMATOMA 4 0.0870
10 POSTURAL REFLEX IMPAIRMENT 3 0.0577
11 MEDIASTINAL CYST 1 0.0556
12 FIRST BITE SYNDROME 2 0.0526
13 EMBOLIC CEREBELLAR INFARCTION 1 0.0476
14 MUCOSAL EXCORIATION 2 0.0465
15 PORTOPULMONARY HYPERTENSION 4 0.0449
16 LATENT SYPHILIS 1 0.0435
17 BOWENOID PAPULOSIS 1 0.0435
18 BETA 2 MICROGLOBULIN URINE INCREASED 6 0.0420
19 HEPATITIS B ANTIGEN POSITIVE 2 0.0417
20 HYPERPHOSPHATASAEMIA 4 0.0364
21 VIRAL LOAD ABNORMAL 6 0.0343
22 DISEASE RISK FACTOR 13 0.0323
23 DIFFUSE MESANGIAL SCLEROSIS 1 0.0323
24 CONGENITAL HYDRONEPHROSIS 22 0.0308
25 AMOEBIC DYSENTERY 3 0.0303
26 SYPHILIS 20 0.0275
27 FEAR-RELATED AVOIDANCE OF ACTIVITIES 4 0.0263
28 PYELOCALIECTASIS 25 0.0261
29 VIRAL LOAD INCREASED 98 0.0252
30 NEUROPSYCHIATRIC LUPUS 3 0.0248
31 ADNEXA UTERI CYST 4 0.0247
32 ADMINISTRATION SITE WARMTH 2 0.0244
33 MISLEADING LABORATORY TEST RESULT 2 0.0241
34 COUGH VARIANT ASTHMA 2 0.0238
35 HIV VIRAEMIA 5 0.0238
36 QUADRANTANOPIA 3 0.0229
37 JOINT DISLOCATION POSTOPERATIVE 1 0.0222
38 SUBSTANCE USE 33 0.0211
39 ACUTE HEPATITIS B 7 0.0211
40 BLOOD HIV RNA INCREASED 37 0.0204
41 MONKEYPOX 5 0.0181
42 ARTERIOVENOUS GRAFT SITE INFECTION 1 0.0179
43 LIPOEDEMA 7 0.0178
44 EX-TOBACCO USER 1 0.0169
45 DERMATOPHYTOSIS OF NAIL 2 0.0168
46 ACROPHOBIA 1 0.0167
47 AIDS DEMENTIA COMPLEX 1 0.0164
48 HYPOTONIC URINARY BLADDER 2 0.0147
49 THROMBOPHLEBITIS SEPTIC 3 0.0146
50 BONE DEMINERALISATION 15 0.0142
51 SENSATION OF BLOOD FLOW 5 0.0131
52 ABSCESS SOFT TISSUE 2 0.0130
53 HYPERHOMOCYSTEINAEMIA 3 0.0115
54 LIPODYSTROPHY ACQUIRED 23 0.0108
55 HEPATITIS B ANTIBODY POSITIVE 2 0.0106
56 HEPATITIS B DNA INCREASED 7 0.0104
57 CONGENITAL MEGAURETER 2 0.0104
58 MYOCARDIAL OEDEMA 4 0.0101
59 VIROLOGIC FAILURE 54 0.0100
60 VAGINAL LESION 3 0.0098
61 ANAL POLYP 1 0.0097
62 RENAL HYPOPLASIA 2 0.0092
63 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 8 0.0092
64 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 1 0.0090
65 INJECTION SITE GRANULOMA 2 0.0084
66 LID SULCUS DEEPENED 3 0.0080
67 HEPATITIS B REACTIVATION 25 0.0079
68 HEPATITIS B DNA ASSAY POSITIVE 1 0.0078
69 MESENTERIC NEOPLASM 1 0.0078
70 BLIGHTED OVUM 3 0.0076
71 LIMB FRACTURE 1 0.0067
72 CHLAMYDIAL INFECTION 5 0.0066
73 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
74 MYOCARDIAL RUPTURE 2 0.0066
75 CHRONIC TONSILLITIS 1 0.0065
76 CHOLESTASIS OF PREGNANCY 3 0.0065
77 CALCULUS URETHRAL 1 0.0065
78 FOETAL GROWTH ABNORMALITY 1 0.0064
79 LIP DISCOLOURATION 8 0.0063
80 FANCONI SYNDROME ACQUIRED 11 0.0063
81 PLASTIC SURGERY 2 0.0062
82 NON-ALCOHOLIC FATTY LIVER 2 0.0059
83 OESOPHAGEAL ULCER HAEMORRHAGE 3 0.0059
84 CONGENITAL CYTOMEGALOVIRUS INFECTION 1 0.0059
85 CYSTIC LYMPHANGIOMA 1 0.0058
86 VIRAEMIA 8 0.0058
87 THALAMUS HAEMORRHAGE 5 0.0057
88 MULTIPLE SYSTEM ATROPHY 2 0.0057
89 ANAL ATRESIA 3 0.0056
90 CATHETER REMOVAL 2 0.0056
91 JEJUNOSTOMY 1 0.0055
92 EOSINOPHILIC COLITIS 2 0.0055
93 INTESTINAL MUCOSAL HYPERTROPHY 1 0.0055
94 HEMIANOPIA HOMONYMOUS 4 0.0055
95 ANHEDONIA 141 0.0054
96 HYDROURETER 2 0.0053
97 TRISOMY 18 2 0.0052
98 MELANODERMA 1 0.0052
99 TINEA PEDIS 8 0.0050
100 BRONCHIAL FISTULA 1 0.0050
101 VIRAL MUTATION IDENTIFIED 18 0.0049
102 ILIUM FRACTURE 1 0.0049
103 VAGINAL ULCERATION 2 0.0048
104 CD4 LYMPHOCYTES DECREASED 10 0.0047
105 BLOOD TRIGLYCERIDES ABNORMAL 4 0.0046
106 LYMPH GLAND INFECTION 2 0.0044
107 MUSCLE MASS 2 0.0044
108 CEREBRAL HYPOPERFUSION 2 0.0043
109 CD4 LYMPHOCYTES INCREASED 1 0.0043
110 CRANIAL NERVE DISORDER 3 0.0043
111 LIPOATROPHY 4 0.0042
112 CANCER IN REMISSION 1 0.0041
113 ECONOMIC PROBLEM 60 0.0040
114 HERPES ZOSTER OTICUS 2 0.0039
115 CREATINE KINASE INCREASED 3 0.0039
116 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
117 HYPERPARATHYROIDISM 8 0.0039
118 AKINESIA 8 0.0039
119 HYPERPROTEINAEMIA 1 0.0038
120 CRIME 1 0.0038
121 HYPERMETABOLISM 2 0.0038
122 GONORRHOEA 1 0.0037
123 HYPERURICAEMIA 15 0.0036
124 DENTAL NECROSIS 1 0.0034
125 PALATAL DISORDER 2 0.0033
126 GENITAL HERPES 5 0.0033
127 COLOUR BLINDNESS 3 0.0033
128 PALLIATIVE CARE 5 0.0033
129 PATHOGEN RESISTANCE 29 0.0032
130 BACTERIAL PYELONEPHRITIS 1 0.0030
131 SOFT TISSUE NECROSIS 2 0.0029
132 RESPIRATORY TRACT IRRITATION 3 0.0029
133 MENINGITIS CRYPTOCOCCAL 5 0.0029
134 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
135 NEONATAL ASPHYXIA 2 0.0028
136 OSTEOPENIA 42 0.0028
137 BRONCHOPNEUMOPATHY 1 0.0027
138 ENTEROBACTER SEPSIS 1 0.0027
139 HEPATITIS B 16 0.0027
140 PERFORATED ULCER 2 0.0026
141 INFECTED SKIN ULCER 5 0.0026
142 LIPID METABOLISM DISORDER 1 0.0026
143 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
144 OSTEOMALACIA 4 0.0026
145 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
146 LIP ERYTHEMA 2 0.0025
147 DEPENDENCE ON RESPIRATOR 1 0.0025
148 HIGH FREQUENCY ABLATION 1 0.0025
149 NEPHROGENIC ANAEMIA 11 0.0024
150 ABDOMINAL CAVITY DRAINAGE 1 0.0024
151 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
152 END STAGE RENAL DISEASE 43 0.0024
153 CAROTID ARTERY DISSECTION 1 0.0023
154 HYPOPITUITARISM 4 0.0023
155 ARTERIAL STENOSIS 2 0.0023
156 CEREBELLAR ATROPHY 2 0.0023
157 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
158 HYPERLEUKOCYTOSIS 2 0.0023
159 MUCOSAL EROSION 2 0.0022
160 FOETAL HEART RATE ABNORMAL 2 0.0022
161 PHARYNGEAL HYPOAESTHESIA 2 0.0022
162 PERIODONTAL DISEASE 3 0.0021
163 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
164 CEREBELLAR HAEMORRHAGE 3 0.0021
165 FACIAL ASYMMETRY 2 0.0021
166 CEREBELLAR ATAXIA 2 0.0021
167 QUALITY OF LIFE DECREASED 28 0.0021
168 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
169 MOTOR NEURONE DISEASE 1 0.0021
170 MUSCLE RUPTURE 8 0.0021
171 NAIL DISCOLOURATION 8 0.0020
172 INTERCEPTED DRUG PRESCRIBING ERROR 1 0.0020
173 MUCOSAL DISORDER 2 0.0020
174 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 10 0.0020
175 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
176 ENTHESOPATHY 3 0.0019
177 URETEROLITHIASIS 2 0.0019
178 ASTERIXIS 2 0.0019
179 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
180 PILOERECTION 2 0.0018
181 HELICOBACTER TEST POSITIVE 1 0.0018
182 STRESS AT WORK 2 0.0018
183 DECREASED ACTIVITY 19 0.0018
184 LIP ULCERATION 2 0.0017
185 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
186 PANCREATIC FAILURE 3 0.0017
187 JUGULAR VEIN THROMBOSIS 3 0.0017
188 INDURATION 3 0.0017
189 GESTATIONAL DIABETES 8 0.0017
190 DIAPHRAGMATIC PARALYSIS 1 0.0017
191 BONE DENSITY DECREASED 52 0.0017
192 LIPOHYPERTROPHY 1 0.0016
193 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
194 RECTAL TENESMUS 2 0.0016
195 HYPERTENSIVE HEART DISEASE 3 0.0016
196 GASTROINTESTINAL TUBE INSERTION 4 0.0016
197 STENOSIS 3 0.0016
198 HYPERLIPIDAEMIA 19 0.0016
199 BLOOD PRESSURE MEASUREMENT 1 0.0016
200 CHRONIC KIDNEY DISEASE 117 0.0015
201 HYPERTRIGLYCERIDAEMIA 9 0.0015
202 OSTEOPOROSIS 63 0.0015
203 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
204 EMBOLIC CEREBRAL INFARCTION 1 0.0015
205 PROTEIN TOTAL INCREASED 4 0.0015
206 LEG AMPUTATION 6 0.0015
207 POLYCYTHAEMIA 3 0.0015
208 DISCHARGE 2 0.0014
209 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
210 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
211 RENAL TUBULAR DISORDER 4 0.0014
212 FANCONI SYNDROME 2 0.0014
213 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
214 HYPERPHOSPHATAEMIA 3 0.0014
215 MULTIPLE CONGENITAL ABNORMALITIES 2 0.0014
216 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
217 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
218 TONGUE BLISTERING 3 0.0013
219 IMPETIGO 2 0.0013
220 INFECTIOUS PLEURAL EFFUSION 2 0.0013
221 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
222 EMOTIONAL DISTRESS 156 0.0013
223 BACTERIAL VAGINOSIS 2 0.0013
224 ESCHERICHIA BACTERAEMIA 3 0.0013
225 HEPATITIS E 2 0.0013
226 DIABETES INSIPIDUS 3 0.0012
227 DRUG RESISTANCE 32 0.0012
228 FEAR OF FALLING 1 0.0012
229 LEUKOCYTURIA 1 0.0012
230 BLOOD URIC ACID INCREASED 7 0.0012
231 IGA NEPHROPATHY 2 0.0012
232 INJECTION SITE ABSCESS 3 0.0012
233 GASTRIC DILATATION 2 0.0012
234 DYSLIPIDAEMIA 6 0.0012
235 HEPATITIS A 1 0.0012
236 NEPHROPATHY 11 0.0012
237 SKIN WOUND 2 0.0012
238 LAZINESS 2 0.0012
239 ABORTION INDUCED 11 0.0012
240 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
241 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
242 PSYCHOTIC DISORDER 34 0.0012
243 IMMOBILE 5 0.0011
244 HISTOPLASMOSIS 2 0.0011
245 VITAMIN D DEFICIENCY 11 0.0011
246 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
247 INJECTION SITE DISCHARGE 6 0.0011
248 PROCTITIS 3 0.0011
249 ENDOTRACHEAL INTUBATION 3 0.0011
250 BONE CYST 1 0.0011
251 PREMATURE LABOUR 6 0.0011
252 BRAIN STEM HAEMORRHAGE 1 0.0011
253 COR PULMONALE 1 0.0010
254 OSTEOPOROTIC FRACTURE 2 0.0010
255 LUMBAR SPINAL STENOSIS 3 0.0010
256 TOOTH LOSS 21 0.0010
257 MESENTERIC VEIN THROMBOSIS 1 0.0010
258 ANORECTAL DISORDER 2 0.0010
259 PROTEIN URINE PRESENT 5 0.0010
260 GASTRECTOMY 1 0.0010
261 CEREBROVASCULAR DISORDER 3 0.0010
262 ANAPHYLACTOID REACTION 4 0.0010
263 IMPULSE-CONTROL DISORDER 2 0.0010
264 CAROTID ARTERIOSCLEROSIS 1 0.0010
265 ANKLE FRACTURE 15 0.0010
266 SPINAL COMPRESSION FRACTURE 8 0.0010
267 COGWHEEL RIGIDITY 1 0.0010
268 EOSINOPHILIC PNEUMONIA 3 0.0010
269 PHARYNGEAL ERYTHEMA 2 0.0009
270 HYPERTENSIVE NEPHROPATHY 1 0.0009
271 JAW FRACTURE 2 0.0009
272 RENAL TUBULAR ACIDOSIS 2 0.0009
273 CEREBELLAR SYNDROME 2 0.0009
274 BIPOLAR I DISORDER 2 0.0009
275 DIABETIC NEPHROPATHY 2 0.0009
276 RHINITIS ALLERGIC 4 0.0009
277 CEREBRAL HAEMATOMA 3 0.0009
278 CRYPTORCHISM 1 0.0009
279 TONGUE ULCERATION 3 0.0009
280 PERIARTHRITIS 2 0.0009
281 HAEMATOCRIT INCREASED 2 0.0009
282 HAEMOGLOBIN INCREASED 4 0.0009
283 BLOODY DISCHARGE 1 0.0009
284 LICHENOID KERATOSIS 2 0.0009
285 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
286 ADMINISTRATION SITE PAIN 1 0.0009
287 BONE LOSS 13 0.0009
288 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
289 CAROTID ARTERY STENOSIS 3 0.0009
290 BILIRUBIN CONJUGATED INCREASED 2 0.0009
291 SPINAL PAIN 10 0.0009
292 MULTIPLE FRACTURES 14 0.0009
293 URINARY TRACT OBSTRUCTION 2 0.0008
294 URINE FLOW DECREASED 2 0.0008
295 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
296 ACUTE PSYCHOSIS 2 0.0008
297 HELICOBACTER GASTRITIS 1 0.0008
298 FRACTURED SACRUM 1 0.0008
299 AMPUTATION 1 0.0008
300 HYPERPARATHYROIDISM SECONDARY 2 0.0008
301 BLOOD CREATININE INCREASED 52 0.0008
302 PRODUCT COMMUNICATION ISSUE 7 0.0008
303 FRACTURED COCCYX 1 0.0008
304 ADENOCARCINOMA PANCREAS 1 0.0008
305 RENAL FAILURE 103 0.0008
306 FOETAL EXPOSURE DURING PREGNANCY 63 0.0008
307 GESTATIONAL HYPERTENSION 1 0.0008
308 RENAL IMPAIRMENT 63 0.0007
309 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
310 GLYCOSURIA 1 0.0007
311 EXPOSURE DURING PREGNANCY 46 0.0007
312 AGORAPHOBIA 1 0.0007
313 NERVE INJURY 8 0.0007
314 AGGRESSION 36 0.0007
315 LIVE BIRTH 6 0.0007
316 HAND FRACTURE 5 0.0007
317 JOINT LOCK 2 0.0007
318 INTENSIVE CARE 1 0.0007
319 FAT TISSUE INCREASED 1 0.0007
320 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
321 GENERALISED ANXIETY DISORDER 1 0.0007
322 CONJUNCTIVITIS ALLERGIC 1 0.0007
323 LUNG ADENOCARCINOMA 2 0.0007
324 NIGHTMARE 23 0.0007
325 HEPATITIS CHOLESTATIC 4 0.0007
326 EPICONDYLITIS 1 0.0007
327 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
328 ANXIETY 186 0.0007
329 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
330 FOREIGN BODY IN THROAT 2 0.0006
331 GASTROINTESTINAL TOXICITY 3 0.0006
332 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
333 TENDON DISORDER 4 0.0006
334 ORAL CANDIDIASIS 8 0.0006
335 NEAR DEATH EXPERIENCE 2 0.0006
336 OTITIS MEDIA 2 0.0006
337 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
338 NEPHRITIS 2 0.0006
339 PRODUCT ADMINISTRATION ERROR 12 0.0006
340 CEREBELLAR INFARCTION 1 0.0006
341 RIB FRACTURE 12 0.0006
342 LEFT VENTRICULAR FAILURE 2 0.0006
343 FOOT FRACTURE 11 0.0006
344 AMYLOIDOSIS 1 0.0006
345 PROTEINURIA 11 0.0006
346 PERIORBITAL OEDEMA 3 0.0006
347 HYPERTRANSAMINASAEMIA 4 0.0006
348 ABORTION SPONTANEOUS 23 0.0006
349 BREAST DISCHARGE 1 0.0006
350 HEART DISEASE CONGENITAL 2 0.0006
351 HAEMORRHAGIC DIATHESIS 2 0.0006
352 CONJUNCTIVAL HYPERAEMIA 2 0.0006
353 RENAL TRANSPLANT 2 0.0006
354 SCLERODERMA 2 0.0005
355 TREATMENT NONCOMPLIANCE 30 0.0005
356 OSTEONECROSIS 18 0.0005
357 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
358 TOOTH FRACTURE 6 0.0005
359 AMYLASE INCREASED 2 0.0005
360 EXERCISE TOLERANCE DECREASED 3 0.0005
361 OESOPHAGEAL ULCER 2 0.0005
362 HYPERCHOLESTEROLAEMIA 5 0.0005
363 DYSSTASIA 15 0.0005
364 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
365 POLYDIPSIA 2 0.0005
366 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
367 GENE MUTATION 1 0.0005
368 EXPOSURE VIA BREAST MILK 2 0.0005
369 OESOPHAGEAL CANDIDIASIS 2 0.0005
370 GOUT 9 0.0005
371 INTRACRANIAL ANEURYSM 2 0.0005
372 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
373 HELICOBACTER INFECTION 5 0.0005
374 PARAESTHESIA ORAL 7 0.0005
375 SKELETAL INJURY 5 0.0005
376 VENTRICULAR EXTRASYSTOLES 5 0.0005
377 INSULIN RESISTANCE 1 0.0005
378 HALLUCINATIONS, MIXED 2 0.0005
379 RENAL PAIN 5 0.0005
380 DEREALISATION 1 0.0005
381 INJECTION SITE INDURATION 6 0.0005
382 OCULAR ICTERUS 2 0.0005
383 CHAPPED LIPS 2 0.0005
384 TOOTH INJURY 2 0.0005
385 NEUROTOXICITY 8 0.0005
386 INJECTION SITE NODULE 5 0.0005
387 HAEMOLYTIC ANAEMIA 4 0.0004
388 VASCULAR DEVICE INFECTION 2 0.0004
389 YELLOW SKIN 2 0.0004
390 FLANK PAIN 4 0.0004
391 SKIN TIGHTNESS 2 0.0004
392 VAGINAL INFECTION 2 0.0004
393 HEPATOCELLULAR INJURY 6 0.0004
394 ATAXIA 5 0.0004
395 DEPRESSION 95 0.0004
396 WRIST FRACTURE 5 0.0004
397 APHAGIA 2 0.0004
398 PRODUCT DISPENSING ERROR 9 0.0004
399 FAECES SOFT 3 0.0004
400 MAJOR DEPRESSION 3 0.0004
401 VITREOUS FLOATERS 4 0.0004
402 BLOOD PRESSURE ABNORMAL 8 0.0004
403 HYDRONEPHROSIS 3 0.0004
404 PANCREATITIS ACUTE 9 0.0004
405 EYELID IRRITATION 1 0.0004
406 EMPHYSEMA 4 0.0004
407 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
408 MEDICATION RESIDUE 1 0.0004
409 RENAL DISORDER 18 0.0004
410 HEPATITIS TOXIC 1 0.0004
411 TONSILLITIS 2 0.0004
412 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
413 RENAL CYST 3 0.0004
414 NYSTAGMUS 2 0.0004
415 MOBILITY DECREASED 27 0.0004
416 IMPAIRED WORK ABILITY 8 0.0004
417 COMPRESSION FRACTURE 2 0.0004
418 ANAL FISSURE 2 0.0004
419 EAR CONGESTION 1 0.0004
420 SLEEP APNOEA SYNDROME 7 0.0004
421 BLOOD PHOSPHORUS INCREASED 1 0.0004
422 ASTHENOPIA 2 0.0004
423 ABNORMAL DREAMS 10 0.0004
424 DRUG SCREEN FALSE POSITIVE 1 0.0004
425 EOSINOPHILIC OESOPHAGITIS 1 0.0004
426 LIVER DISORDER 16 0.0004
427 TRANSAMINASES INCREASED 8 0.0004
428 POLLAKIURIA 15 0.0004
429 DEPRESSED MOOD 19 0.0004
430 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
431 MYOCARDITIS 4 0.0003
432 DYSPNOEA AT REST 1 0.0003
433 SKIN WARM 2 0.0003
434 NIGHT SWEATS 11 0.0003
435 PRODUCT DOSE OMISSION ISSUE 100 0.0003
436 ACUTE KIDNEY INJURY 52 0.0003
437 OESOPHAGEAL CARCINOMA 10 0.0003
438 HAEMARTHROSIS 3 0.0003
439 LIP SWELLING 11 0.0003
440 LIP DRY 3 0.0003
441 FOETAL GROWTH RESTRICTION 2 0.0003
442 DIABETES MELLITUS 25 0.0003
443 EPILEPSY 10 0.0003
444 CYTOPENIA 4 0.0003
445 DYSAESTHESIA 1 0.0003
446 LIVER FUNCTION TEST INCREASED 7 0.0003
447 ECTOPIC PREGNANCY 1 0.0003
448 PRODUCT DISTRIBUTION ISSUE 3 0.0003
449 CHOLANGITIS 2 0.0003
450 HEPATIC STEATOSIS 6 0.0003
451 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 58 0.0003
452 APPENDICITIS 3 0.0003
453 INJECTION SITE HYPERSENSITIVITY 1 0.0003
454 ARTERIOSCLEROSIS 3 0.0003
455 FRACTURE 6 0.0003
456 MUSCLE ATROPHY 4 0.0003
457 HEPATOTOXICITY 7 0.0003
458 OBESITY 5 0.0003
459 FOREIGN BODY SENSATION IN EYES 2 0.0003
460 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
461 ERECTILE DYSFUNCTION 8 0.0003
462 GLAUCOMA 6 0.0003
463 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
464 HERPES SIMPLEX 2 0.0003
465 FACET JOINT SYNDROME 1 0.0003
466 NODULE 4 0.0003
467 RENAL INJURY 9 0.0003
468 DRUG LEVEL INCREASED 5 0.0003
469 SKIN MASS 2 0.0003
470 POST-TRAUMATIC STRESS DISORDER 2 0.0003
471 WRONG PRODUCT ADMINISTERED 2 0.0003
472 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
473 BODY TEMPERATURE INCREASED 6 0.0003
474 INITIAL INSOMNIA 3 0.0003
475 PAIN 179 0.0003
476 BLOOD CREATININE ABNORMAL 1 0.0003
477 MUSCULOSKELETAL PAIN 15 0.0003
478 FOLLICULITIS 3 0.0003
479 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
480 SLEEP DISORDER 20 0.0003
481 FACIAL BONES FRACTURE 1 0.0003
482 TREATMENT FAILURE 23 0.0003
483 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
484 MOUTH HAEMORRHAGE 2 0.0003
485 HEPATIC FUNCTION ABNORMAL 10 0.0003
486 BONE DENSITY ABNORMAL 1 0.0003
487 NEPHROPATHY TOXIC 3 0.0003
488 PREMATURE BABY 8 0.0003
489 LOSS OF CONTROL OF LEGS 1 0.0003
490 HIP ARTHROPLASTY 4 0.0003
491 CLAVICLE FRACTURE 1 0.0003
492 LYMPHOMA 4 0.0003
493 NICOTINE DEPENDENCE 2 0.0003
494 CARDIOPULMONARY FAILURE 1 0.0003
495 NERVOUS SYSTEM DISORDER 8 0.0003
496 EPIGASTRIC DISCOMFORT 1 0.0003
497 DYSPHAGIA 24 0.0003
498 SEPTIC SHOCK 11 0.0003
499 NEUROPATHY PERIPHERAL 24 0.0003
500 LOW BIRTH WEIGHT BABY 2 0.0003
501 SCIATICA 4 0.0003
502 MUSCLE RIGIDITY 3 0.0003
503 HEPATITIS C 3 0.0002
504 ENURESIS 1 0.0002
505 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
506 GAIT DISTURBANCE 47 0.0002
507 ANGINA PECTORIS 7 0.0002
508 ABNORMAL FAECES 2 0.0002
509 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
510 ACUTE CORONARY SYNDROME 2 0.0002
511 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
512 CONGESTIVE CARDIOMYOPATHY 1 0.0002
513 TINNITUS 11 0.0002
514 SKIN DISCOLOURATION 11 0.0002
515 PRODUCT COMPLAINT 6 0.0002
516 HYPOPHAGIA 6 0.0002
517 FACIAL PARALYSIS 2 0.0002
518 INTERVERTEBRAL DISC DISORDER 1 0.0002
519 OCULAR HYPERAEMIA 11 0.0002
520 PSYCHOLOGICAL TRAUMA 2 0.0002
521 PYELONEPHRITIS 2 0.0002
522 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
523 INCORRECT PRODUCT STORAGE 3 0.0002
524 EOSINOPHILIA 4 0.0002
525 DYSPHEMIA 1 0.0002
526 SPINAL OSTEOARTHRITIS 2 0.0002
527 DRUG INTERACTION 36 0.0002
528 DRUG ERUPTION 4 0.0002
529 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
530 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
531 BLOOD BILIRUBIN INCREASED 6 0.0002
532 DYSKINESIA 9 0.0002
533 OROPHARYNGEAL DISCOMFORT 2 0.0002
534 HEART RATE IRREGULAR 5 0.0002
535 DISEASE COMPLICATION 1 0.0002
536 LUMBAR VERTEBRAL FRACTURE 1 0.0002
537 NEPHROLITHIASIS 10 0.0002
538 HIP FRACTURE 7 0.0002
539 RETINAL DETACHMENT 2 0.0002
540 NERVE COMPRESSION 2 0.0002
541 PERSONALITY CHANGE 2 0.0002
542 BLOOD CHOLESTEROL INCREASED 10 0.0002
543 ERYTHEMA MULTIFORME 2 0.0002
544 FEELING OF DESPAIR 1 0.0002
545 DEFORMITY 2 0.0002
546 SKIN REACTION 3 0.0002
547 OSTEOARTHRITIS 9 0.0002
548 VISUAL ACUITY REDUCED 7 0.0002
549 PARALYSIS 3 0.0002
550 SUICIDAL IDEATION 19 0.0002
551 HUMERUS FRACTURE 1 0.0002
552 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
553 SINUS BRADYCARDIA 2 0.0002
554 CEREBRAL INFARCTION 5 0.0002
555 THERAPY CHANGE 2 0.0002
556 FOOT OPERATION 1 0.0002
557 COLON CANCER 3 0.0002
558 HYPERKALAEMIA 7 0.0002
559 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
560 VAGINAL DISCHARGE 2 0.0002
561 CORONARY ARTERIAL STENT INSERTION 1 0.0002
562 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
563 FEMORAL NECK FRACTURE 1 0.0002
564 ENDOCARDITIS 1 0.0002
565 FOETAL DEATH 1 0.0002
566 EYE DISCHARGE 2 0.0002
567 HYPERGLYCAEMIA 7 0.0002
568 TENDERNESS 2 0.0002
569 RHABDOMYOLYSIS 8 0.0002
570 APLASTIC ANAEMIA 1 0.0002
571 WEIGHT FLUCTUATION 2 0.0002
572 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
573 BLOOD LACTIC ACID INCREASED 1 0.0002
574 SCRATCH 2 0.0002
575 INCONTINENCE 2 0.0002
576 INSOMNIA 50 0.0002
577 IRRITABLE BOWEL SYNDROME 4 0.0002
578 CHEST DISCOMFORT 19 0.0002
579 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
580 BIPOLAR DISORDER 2 0.0002
581 SUICIDE ATTEMPT 11 0.0002
582 GAIT INABILITY 6 0.0002
583 ORAL PAIN 4 0.0002
584 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
585 CHROMATURIA 4 0.0002
586 THERAPY CESSATION 9 0.0002
587 MUSCULOSKELETAL DISCOMFORT 3 0.0002
588 ENTEROCOLITIS 1 0.0002
589 PERICARDIAL EFFUSION 4 0.0002
590 METABOLIC DISORDER 1 0.0002
591 EYELID OEDEMA 2 0.0002
592 CAESAREAN SECTION 2 0.0002
593 RASH MACULAR 6 0.0002
594 DECREASED INTEREST 1 0.0002
595 ACUTE MYOCARDIAL INFARCTION 5 0.0002
596 DISEASE RECURRENCE 8 0.0002
597 PRODUCT PRESCRIBING ERROR 4 0.0002
598 CHOLECYSTITIS 2 0.0002
599 POLYNEUROPATHY 2 0.0002
600 ADRENAL INSUFFICIENCY 2 0.0002
601 NOCTURIA 2 0.0002
602 MYALGIA 28 0.0002
603 DERMATITIS ACNEIFORM 1 0.0002
604 VERTIGO 10 0.0002
605 DYSURIA 6 0.0002
606 MENISCUS INJURY 1 0.0002
607 PNEUMONIA ASPIRATION 4 0.0002
608 INJECTION SITE PAIN 49 0.0002
609 SECRETION DISCHARGE 2 0.0002
610 DRUG-INDUCED LIVER INJURY 5 0.0002
611 DYSPNOEA EXERTIONAL 6 0.0002
612 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
613 GASTRIC ULCER 3 0.0002
614 MUSCULOSKELETAL DISORDER 3 0.0002
615 HEPATIC CYTOLYSIS 2 0.0002
616 MOOD SWINGS 5 0.0002
617 INJECTION SITE SWELLING 12 0.0002
618 EYE IRRITATION 9 0.0002
619 POST PROCEDURAL COMPLICATION 3 0.0002
620 DRUG PRESCRIBING ERROR 3 0.0002
621 LOWER LIMB FRACTURE 3 0.0002
622 ADVERSE DRUG REACTION 14 0.0002
623 RASH GENERALISED 4 0.0002
624 EXPOSURE VIA SKIN CONTACT 4 0.0002
625 RASH 67 0.0002
626 PLATELET COUNT INCREASED 2 0.0002
627 CHOLELITHIASIS 5 0.0002
628 IMMUNE SYSTEM DISORDER 2 0.0002
629 CORONAVIRUS INFECTION 1 0.0002
630 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
631 BACK PAIN 35 0.0002
632 SYNCOPE 15 0.0001
633 SKIN DISORDER 5 0.0001
634 SPINAL FRACTURE 3 0.0001
635 PRODUCT USE ISSUE 28 0.0001
636 PRODUCT PHYSICAL ISSUE 3 0.0001
637 TYPE 2 DIABETES MELLITUS 5 0.0001
638 INTENTIONAL PRODUCT MISUSE 13 0.0001
639 FEEDING DISORDER 3 0.0001
640 ANGER 5 0.0001
641 ABNORMAL LOSS OF WEIGHT 1 0.0001
642 MOOD ALTERED 4 0.0001
643 HEADACHE 91 0.0001
644 CHILLS 17 0.0001
645 RESPIRATORY DISTRESS 4 0.0001
646 MOUTH ULCERATION 3 0.0001
647 OXYGEN SATURATION DECREASED 8 0.0001
648 BLINDNESS UNILATERAL 2 0.0001
649 LYMPHOPENIA 2 0.0001
650 SEASONAL ALLERGY 2 0.0001
651 SWELLING FACE 9 0.0001
652 ANOSMIA 2 0.0001
653 DERMATITIS BULLOUS 1 0.0001
654 MENTAL DISORDER 6 0.0001
655 PRODUCT PRESCRIBING ISSUE 3 0.0001
656 LIVER FUNCTION TEST ABNORMAL 4 0.0001
657 GASTROENTERITIS 2 0.0001
658 HOSPITALISATION 21 0.0001
659 PALPITATIONS 16 0.0001
660 STEVENS-JOHNSON SYNDROME 3 0.0001
661 HAEMORRHAGE INTRACRANIAL 2 0.0001
662 ACIDOSIS 1 0.0001
663 LIPASE INCREASED 1 0.0001
664 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
665 OROPHARYNGEAL PAIN 12 0.0001
666 FOOD ALLERGY 1 0.0001
667 ACUTE MYELOID LEUKAEMIA 2 0.0001
668 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
669 BALANCE DISORDER 11 0.0001
670 AFFECTIVE DISORDER 1 0.0001
671 PRODUCT USE COMPLAINT 2 0.0001
672 DRUG SCREEN POSITIVE 1 0.0001
673 PREMATURE DELIVERY 2 0.0001
674 COVID-19 22 0.0001
675 ABDOMINAL DISCOMFORT 21 0.0001
676 MOVEMENT DISORDER 4 0.0001
677 MENTAL IMPAIRMENT 3 0.0001
678 PRESYNCOPE 3 0.0001
679 FATIGUE 96 0.0001
680 ARTHRALGIA 51 0.0001
681 LUNG DISORDER 6 0.0001
682 DYSPEPSIA 12 0.0001
683 HICCUPS 1 0.0001
684 HERPES ZOSTER 7 0.0001
685 HYPERAESTHESIA 1 0.0001
686 FUNGAL INFECTION 4 0.0001
687 EOSINOPHIL COUNT INCREASED 1 0.0001
688 ASTHENIA 45 0.0001
689 CARDIO-RESPIRATORY ARREST 5 0.0001
690 HAEMODIALYSIS 1 0.0001
691 DRUG USE DISORDER 1 0.0001
692 HAEMATEMESIS 3 0.0001
693 HEPATITIS 3 0.0001
694 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
695 HYPERHIDROSIS 15 0.0001
696 CARDIAC OPERATION 1 0.0001
697 ANURIA 1 0.0001
698 STOMATITIS 7 0.0001
699 ILL-DEFINED DISORDER 7 0.0001
700 ORTHOSTATIC HYPOTENSION 2 0.0001
701 JOINT STIFFNESS 3 0.0001
702 DRUG INTOLERANCE 11 0.0001
703 COLD SWEAT 2 0.0001
704 URTICARIA 19 0.0001
705 LUNG INFILTRATION 1 0.0001
706 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
707 WEIGHT INCREASED 25 0.0001
708 GASTROINTESTINAL DISORDER 10 0.0001
709 GASTROINTESTINAL INFECTION 1 0.0001
710 JAUNDICE 3 0.0001
711 THROAT IRRITATION 5 0.0001
712 LOSS OF LIBIDO 1 0.0001
713 TOOTHACHE 2 0.0001
714 PALLOR 3 0.0001
715 CRYING 4 0.0001
716 PANIC ATTACK 4 0.0001
717 LOSS OF CONSCIOUSNESS 14 0.0001
718 MEMORY IMPAIRMENT 15 0.0001
719 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
720 HYPERTENSION 23 0.0001
721 CHEST PAIN 20 0.0001
722 CONJUNCTIVITIS 2 0.0001
723 EYE SWELLING 4 0.0001
724 BLISTER 6 0.0001
725 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
726 HEPATIC CIRRHOSIS 2 0.0001
727 PHOTOPHOBIA 2 0.0001
728 FEELING JITTERY 2 0.0001
729 RED BLOOD CELL COUNT DECREASED 3 0.0001
730 PRODUCTIVE COUGH 5 0.0001
731 HYPERSOMNIA 3 0.0001
732 SOMNOLENCE 21 0.0001
733 AFFECT LABILITY 1 0.0001
734 PRESCRIBED OVERDOSE 2 0.0001
735 PRODUCT STORAGE ERROR 9 0.0001
736 HEPATIC ENZYME INCREASED 7 0.0001
737 AUTOIMMUNE DISORDER 1 0.0001
738 HAEMORRHOIDS 2 0.0001
739 CHOKING 2 0.0001
740 SURGERY 6 0.0001
741 ASCITES 3 0.0001
742 CONDITION AGGRAVATED 31 0.0001
743 BLADDER DISORDER 1 0.0001
744 ANAEMIA 19 0.0001
745 LACRIMATION INCREASED 3 0.0001
746 BONE MARROW FAILURE 2 0.0001
747 DISCOMFORT 6 0.0001
748 DRUG LEVEL DECREASED 1 0.0001
749 ADVERSE EVENT 9 0.0001
750 INJECTION SITE WARMTH 2 0.0001
751 ILLNESS 10 0.0001
752 HYPERBILIRUBINAEMIA 1 0.0001
753 SWOLLEN TONGUE 3 0.0001
754 NAUSEA 76 0.0001
755 SPEECH DISORDER 5 0.0001
756 HALLUCINATION, VISUAL 2 0.0001
757 BREAST PAIN 1 0.0001
758 PRURITUS 36 0.0001
759 POOR QUALITY SLEEP 2 0.0001
760 LACTIC ACIDOSIS 3 0.0001
761 RASH PRURITIC 5 0.0001
762 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
763 NECK PAIN 5 0.0001
764 THROMBOCYTOPENIA 10 0.0001
765 MALNUTRITION 1 0.0001
766 EYE PRURITUS 3 0.0001
767 SNEEZING 2 0.0001
768 FISTULA 1 0.0001
769 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
770 DERMATITIS CONTACT 1 0.0001
771 FEELING ABNORMAL 21 0.0001
772 MICTURITION URGENCY 1 0.0001
773 CARDIAC FAILURE 7 0.0001
774 LETHARGY 5 0.0001
775 COGNITIVE DISORDER 4 0.0001
776 CARDIAC DISORDER 8 0.0001
777 VOMITING 40 0.0001
778 COVID-19 PNEUMONIA 1 0.0001
779 PERIPHERAL SWELLING 13 0.0001
780 COMPLETED SUICIDE 7 0.0001
781 CEREBRAL HAEMORRHAGE 3 0.0001
782 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
783 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
784 RESTLESSNESS 3 0.0001
785 EXTRAPYRAMIDAL DISORDER 2 0.0001
786 AGEUSIA 2 0.0001
787 CELLULITIS 4 0.0001
788 INJECTION SITE IRRITATION 1 0.0001
789 PYREXIA 27 0.0001
790 ABDOMINAL PAIN 18 0.0001
791 SKIN ULCER 2 0.0001
792 BEDRIDDEN 1 0.0001
793 GASTRITIS 2 0.0001
794 DISORIENTATION 3 0.0001
795 DYSMENORRHOEA 1 0.0001
796 HYPERSENSITIVITY 14 0.0001
797 CARDIAC FAILURE CONGESTIVE 6 0.0001
798 MENSTRUATION IRREGULAR 2 0.0001
799 DIZZINESS 37 0.0001
800 DISTURBANCE IN ATTENTION 4 0.0001
801 OEDEMA PERIPHERAL 9 0.0001
802 MALAISE 32 0.0001
803 INJECTION SITE REACTION 5 0.0001
804 ANAPHYLACTIC REACTION 4 0.0001
805 FALL 24 0.0001
806 ARTHROPATHY 4 0.0001
807 SEPSIS 8 0.0001
808 PANCYTOPENIA 4 0.0001
809 MASS 1 0.0001
810 WOUND 2 0.0001
811 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
812 MUSCLE SPASMS 13 0.0001
813 DIALYSIS 1 0.0001
814 RHEUMATOID ARTHRITIS 8 0.0001
815 PARAESTHESIA 11 0.0001
816 HYPERTHYROIDISM 1 0.0001
817 MYOCARDIAL INFARCTION 12 0.0001
818 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
819 ANGIOEDEMA 3 0.0001
820 HALLUCINATION 5 0.0001
821 HEPATIC FAILURE 2 0.0001
822 OFF LABEL USE 58 0.0001
823 VISION BLURRED 9 0.0001
824 SKIN IRRITATION 3 0.0001
825 DRUG DISPENSING ERROR 1 0.0001
826 INSURANCE ISSUE 1 0.0001
827 NASOPHARYNGITIS 12 0.0001
828 DEVICE RELATED INFECTION 1 0.0001
829 DECREASED APPETITE 15 0.0001
830 WEIGHT DECREASED 18 0.0001
831 DELUSION 1 0.0001
832 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
833 ARTHRITIS 5 0.0001
834 ABDOMINAL PAIN UPPER 13 0.0001
835 ABSCESS 1 0.0001
836 METABOLIC ACIDOSIS 2 0.0001
837 DIARRHOEA 40 0.0001
838 INTERSTITIAL LUNG DISEASE 3 0.0001
839 RHINORRHOEA 4 0.0001
840 PNEUMONIA 20 0.0001
841 BLOOD POTASSIUM INCREASED 1 0.0001
842 BACK DISORDER 1 0.0001
843 PAIN IN EXTREMITY 18 0.0001
844 INFLUENZA LIKE ILLNESS 5 0.0001
845 SEIZURE 7 0.0001
846 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
847 DRY EYE 3 0.0001
848 VIRAL INFECTION 2 0.0001
849 BLOOD UREA INCREASED 1 0.0001
850 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
851 NEUTROPENIA 8 0.0001
852 HAEMOGLOBIN DECREASED 6 0.0001
853 DYSPNOEA 33 0.0001
854 GASTRIC DISORDER 2 0.0001
855 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
856 ABDOMINAL DISTENSION 6 0.0001
857 MUSCULOSKELETAL STIFFNESS 5 0.0001
858 BURNING SENSATION 4 0.0001
859 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
860 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
861 TACHYCARDIA 5 0.0001
862 ISCHAEMIC STROKE 1 0.0001
863 MYELOSUPPRESSION 2 0.0001
864 LEUKOCYTOSIS 1 0.0001
865 BONE DISORDER 1 0.0001
866 AGRANULOCYTOSIS 1 0.0001
867 COUGH 15 0.0001
868 HYPOAESTHESIA 8 0.0001
869 SWELLING 5 0.0001
870 CEREBROVASCULAR ACCIDENT 9 0.0001
871 BLOOD URINE PRESENT 1 0.0001
872 INCREASED APPETITE 1 0.0001
873 ERUCTATION 1 0.0001
874 BONE PAIN 3 0.0001
875 DISABILITY 1 0.0001
876 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
877 FULL BLOOD COUNT DECREASED 1 0.0000
878 CONFUSIONAL STATE 8 0.0000
879 FLUSHING 5 0.0000
880 BLINDNESS 2 0.0000
881 FEELING HOT 3 0.0000
882 SINUSITIS 5 0.0000
883 DEATH 42 0.0000
884 ERYTHEMA 10 0.0000
885 CARDIAC ARREST 4 0.0000
886 INJECTION SITE ERYTHEMA 6 0.0000
887 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
888 ROAD TRAFFIC ACCIDENT 2 0.0000
889 RENAL FAILURE ACUTE 2 0.0000
890 EATING DISORDER 1 0.0000
891 RECTAL HAEMORRHAGE 2 0.0000
892 HYPOACUSIS 2 0.0000
893 FAECES DISCOLOURED 1 0.0000
894 BLOOD PRESSURE INCREASED 7 0.0000
895 FEBRILE NEUTROPENIA 3 0.0000
896 DEHYDRATION 6 0.0000
897 NEOPLASM MALIGNANT 3 0.0000
898 INFLUENZA 5 0.0000
899 PULMONARY OEDEMA 2 0.0000
900 ASTHMA 5 0.0000
901 BLOOD GLUCOSE INCREASED 8 0.0000
902 DRUG DOSE OMISSION 7 0.0000
903 MIGRAINE 4 0.0000
904 OVERDOSE 9 0.0000
905 BLOOD PRESSURE FLUCTUATION 1 0.0000
906 DIABETIC KETOACIDOSIS 1 0.0000
907 HEPATIC CANCER 1 0.0000
908 UNDERDOSE 3 0.0000
909 AGITATION 3 0.0000
910 ABDOMINAL PAIN LOWER 1 0.0000
911 INCORRECT DOSE ADMINISTERED 9 0.0000
912 HAEMORRHAGE 4 0.0000
913 DEAFNESS 1 0.0000
914 PANCREATITIS 2 0.0000
915 BRADYCARDIA 2 0.0000
916 FEAR 1 0.0000
917 HAEMATOCHEZIA 2 0.0000
918 DIVERTICULITIS 1 0.0000
919 MENTAL STATUS CHANGES 1 0.0000
920 FEELING COLD 1 0.0000
921 HYPONATRAEMIA 2 0.0000
922 EYE PAIN 2 0.0000
923 URINARY TRACT INFECTION 6 0.0000
924 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
925 NASAL CONGESTION 2 0.0000
926 LABORATORY TEST ABNORMAL 1 0.0000
927 CATARACT 2 0.0000
928 APHASIA 1 0.0000
929 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
930 INJECTION SITE RASH 1 0.0000
931 DRUG ADMINISTRATION ERROR 1 0.0000
932 EMOTIONAL DISORDER 1 0.0000
933 GYNAECOMASTIA 1 0.0000
934 LIMB DISCOMFORT 1 0.0000
935 FEMUR FRACTURE 1 0.0000
936 CONSTIPATION 7 0.0000
937 CYSTITIS 1 0.0000
938 AMNESIA 2 0.0000
939 PRODUCT DOSE OMISSION 2 0.0000
940 INFUSION RELATED REACTION 2 0.0000
941 BLOOD PRESSURE DECREASED 2 0.0000
942 HAEMATURIA 1 0.0000
943 DELIRIUM 1 0.0000
944 LYMPHADENOPATHY 1 0.0000
945 PLATELET COUNT DECREASED 3 0.0000
946 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
947 INFECTION 4 0.0000
948 DRUG EFFECT INCOMPLETE 1 0.0000
949 C-REACTIVE PROTEIN INCREASED 1 0.0000
950 ACCIDENTAL OVERDOSE 1 0.0000
951 INJECTION SITE MASS 1 0.0000
952 DYSGEUSIA 2 0.0000
953 EPISTAXIS 2 0.0000
954 DYSARTHRIA 1 0.0000
955 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
956 INJECTION SITE HAEMORRHAGE 2 0.0000
957 EXTRA DOSE ADMINISTERED 1 0.0000
958 TREMOR 4 0.0000
959 TOXICITY TO VARIOUS AGENTS 4 0.0000
960 DRUG INEFFECTIVE 31 0.0000
961 COLITIS ULCERATIVE 1 0.0000
962 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
963 BLOOD GLUCOSE DECREASED 1 0.0000
964 HEART RATE INCREASED 2 0.0000
965 LEUKOPENIA 1 0.0000
966 HYPOTENSION 4 0.0000
967 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
968 INFLAMMATION 1 0.0000
969 MEDICATION ERROR 1 0.0000
970 MUSCULAR WEAKNESS 2 0.0000
971 CONVULSION 1 0.0000
972 DYSPHONIA 1 0.0000
973 NO ADVERSE EVENT 3 0.0000
974 INTENTIONAL OVERDOSE 1 0.0000
975 DEEP VEIN THROMBOSIS 1 0.0000
976 ALOPECIA 3 0.0000
977 DRY SKIN 2 0.0000
978 INJECTION SITE PRURITUS 1 0.0000
979 PRODUCT QUALITY ISSUE 2 0.0000
980 INJURY 1 0.0000
981 BRONCHITIS 1 0.0000
982 HOT FLUSH 1 0.0000
983 ACNE 1 0.0000
984 DRY MOUTH 1 0.0000
985 ATRIAL FIBRILLATION 1 0.0000
986 JOINT SWELLING 1 0.0000